By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Knopp Biosciences 

2100 Wharton Street
Suite 615
Pittsburgh  Philadephia  15203  U.S.A.
Phone: 412-488-1776 Fax: n/a



Company News
Knopp Biosciences Announces NIH Blueprint Grant Award For Advancing Novel Neonatal Epilepsy Treatments 2/16/2017 6:31:46 AM
Knopp Biosciences Release: Company Receives Key Patent Directed To Ion Channel Activators For Brain Disorders 1/26/2017 9:01:42 AM
Knopp Biosciences Receives Key Patent Directed To Treatment For Hypereosinophilic Syndromes, Asthma, And Other Eosinophilic Diseases 1/4/2017 9:43:20 AM
Calman Prussin, M.D., Joins Knopp Biosciences To Lead Clinical Development Of Dexpramipexole In Eosinophilic Asthma 1/7/2016 1:27:56 PM
Knopp Biosciences Broadens Collaboration With National Institutes of Health (NIH) To Investigate Eosinophil-Lowering Effects Of Dexpramipexole 3/13/2014 8:59:43 AM
Knopp Biosciences And National Institutes of Health (NIH) To Collaborate In Evaluating Dexpramipexole In Patients With Hypereosinophilic Syndrome 1/8/2014 9:37:22 AM
Knopp Biosciences Partners With MMS Holdings, Inc. to Manage Pharmacovigilance Services 8/1/2013 12:50:09 PM
Albany Molecular Research, Inc. (AMRI) (AMRI) Announces Strategic Contract With Knopp Biosciences 9/17/2012 10:31:20 AM
Knopp Biosciences Announces Recruiting of Key Scientific Executives and Completion of Laboratory Expansion 5/2/2012 10:14:11 AM
Data from Phase 2 Study of Knopp Biosciences's Dexpramipexole in ALS Published in Nature Medicine 11/21/2011 8:44:22 AM